Initial evidence in support of such a mechanism comes from Mo et al., who reported the expression of PD-L1 on peripheral nerve fibers from the stroma of prostate cancer using a novel monoclonal antibody against PD-L1. The gene discussed is CD274; the disease is prostate cancer.